Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topiramate for migraine prevention has completed, assessing its efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Migraine, Common Migraine | Phase 3 | Status: COMPLETED